The Friedrich Loeffler Institute in Germany has announced the successful testing of an experimental mRNA vaccine against foot-and-mouth disease (FMD), which could improve virus management. This vaccine uses fragments of the virus's genetic code, avoiding the need to manipulate live virus, making it safer. In tests, vaccinated cows showed no symptoms and shed less virus than unvaccinated cows. This is a significant achievement, given that foot-and-mouth disease severely affects animals but poses no risk to humans. Further studies are underway to approve the vaccine.
Sources
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin împotriva febrei aftoase. Acesta folosește tehnologia ARNm
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Latest News
21:57
Alexandru Nazare estimates the beginning of deflation this autumn.
21:39
Volodymyr Zelensky will make a visit to Serbia on Saturday, marking his first trip to this country since the beginning of the Russian invasion.
21:35
The authorities in Turkey announced the discovery of a statue group in Aspendos, representing the god of medicine Asklepios and his son Telesphoros.
21:19
France prohibits unsolicited commercial calls: fines of up to 375,000 euros for companies
21:09
Minister Irineu Darău initiated a dialogue with the management of companies and unions in the defense industry to identify solutions for increasing competitiveness.
See more news